| Containers & Packaging Industry | Materials Sector | - CEO | HKEX Exchange | G215AV206 CUSIP |
| Hong Kong Country | 465 Employees | - Last Dividend | 12 Aug 2019 Last Split | - IPO Date |
Touyun Biotech Group Limited stands as a notable investment holding entity specializing in the design, development, manufacturing, and sale of various packaging products. Headquartered in Wan Chai, Hong Kong since its inception in 1989, the company has significantly expanded its reach, serving multiple markets including Hong Kong, the People's Republic of China, Europe, North and South America, and other international regions. Formerly known as China Touyun Tech Group Limited until its rebranding in May 2021, Touyun Biotech Group Limited has diversified its operations across four primary segments: QR Code Business, Packaging Products Business, Treasury Investment Business, and Chlamydomonas Reinhardtii Products Business. With a commitment to innovation and quality, Touyun Biotech Group Limited aims to address the evolving needs of its global clientele through its wide range of products and services.
This segment focuses on leveraging QR code technology for product packaging solutions, advertising display services, and enhanced product traceability and security for clients. By integrating QR codes on packaging, Touyun Biotech provides a seamless connection between physical products and digital information, supporting marketing efforts and consumer engagement.
As a core aspect of its operations, this segment manufactures and sells a premium assortment of packaging products, including watch and jewelry boxes, eyewear cases, bags and pouches, and display units designed for luxury and high-value items. These products are tailored to meet the exquisite presentation and preservation needs of clients across various industries.
This division extends beyond Touyun Biotech's primary manufacturing focus, engaging in the investment and trading of securities. It envelops services such as money lending, placing and underwriting, securities brokerage, and margin financing. This multifaceted approach towards investment and financial services underscores the company’s diverse business strategies.
In a unique blend of biotechnology with its existing offerings, this segment specializes in the production and sale of Chlamydomonas Reinhardtii, a type of micro-algae. Known for its potential health benefits and applications in biotechnological research, these products represent Touyun Biotech’s venture into the burgeoning field of biotech, indicating a move towards sustainable and innovative product lines.
In addition to its main product lines, Touyun Biotech offers cutting-edge business intelligence IT solutions that aid in data management, analytics, and decision-making processes for businesses. The company also delivers online advertising display services, facilitating broader marketing reach and engagement for its clients' products and services.
This comprehensive suite of services provided by Touyun Biotech includes managing both tangible and intangible assets, offering advice and solutions for corporate management issues. These services are designed to optimize operational efficiency, financial performance, and strategic planning for businesses.